FBT
First Trust NYSE Arca Biotechnology Index Fund
Price Chart
Latest Quote
$248.48
-0.80 (-0.32%)
Current Price
| Previous Close | $249.28 |
| Open | $247.08 |
| Day High | $249.90 |
| Day Low | $247.18 |
| Volume | 18,527 |
Fund Information
| Shares Outstanding | 20.85M |
| Net Assets | $2.81B |
| Expense Ratio | 0.55% |
| Category | Health |
| Fund Family | First Trust |
| Net Asset Value | $249.19 |
| Premium/Discount | -0.28% |
| P/E Ratio | 30.10 |
| Exchange | PCX |
đ ETF Analysis
Company Data
| Book/sh | $172.68 |
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| P/B | 1.44 |
Analyst Data
Technical Indicators
| SMA20 | $246.29 |
| SMA50 | $228.89 |
| SMA200 | $209.77 |
| RSI | 52.69 |
| ATR | 3.7264 |
| Rel Volume | 0.24 |
Performance History
| Week | -0.44% |
| Month | +9.74% |
| Quarter | +20.56% |
| 6 Months | +15.78% |
| YTD | +19.62% |
| Year | +50.42% |
| 3 Years | +62.42% |
| 5 Years | +46.58% |
| 10 Years | +170.13% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $248.48 | 19,000 |
| 2026-07-16 | $249.28 | 26,900 |
| 2026-07-15 | $247.63 | 34,000 |
| 2026-07-14 | $246.00 | 24,700 |
| 2026-07-13 | $247.54 | 28,200 |
| 2026-07-10 | $249.59 | 31,400 |
| 2026-07-09 | $256.01 | 87,000 |
| 2026-07-08 | $253.61 | 30,400 |
| 2026-07-07 | $256.19 | 42,100 |
| 2026-07-06 | $255.60 | 57,400 |
| 2026-07-02 | $255.37 | 40,000 |
| 2026-07-01 | $249.26 | 56,200 |
| 2026-06-30 | $247.89 | 54,000 |
| 2026-06-29 | $247.63 | 368,300 |
| 2026-06-26 | $246.96 | 530,700 |
| 2026-06-25 | $242.17 | 45,400 |
| 2026-06-24 | $237.29 | 39,700 |
| 2026-06-23 | $230.61 | 15,000 |
| 2026-06-22 | $229.79 | 33,100 |
| 2026-06-18 | $228.85 | 25,500 |
About First Trust NYSE Arca Biotechnology Index Fund
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.
đ° Latest News
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
Zacks âĸ 2026-07-10T10:20:02Z
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
Zacks âĸ 2026-07-02T10:20:02Z
Biotech Could Be One of 2026âs Biggest Winners, and This ETF Is Perfectly Positioned
24/7 Wall St. âĸ 2026-01-09T12:55:05Z
Inside the Recent Strength in Biotech ETFs
Zacks âĸ 2025-11-21T13:00:00Z
2 ETFs to Watch for Outsized Volume on Biotechnology Stocks
Zacks âĸ 2025-11-18T13:46:00Z
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.